Search

everythinglearnresearchcommunity

for

Search:↓

Many dermatology patients experienced anxiety, depression, PTSD, and skin issues after the February 6, 2023 earthquakes, highlighting the need for combined skin and mental health care.

Solanum nigrum shows promise for treating COVID-19 and its complications, but more research is needed.

Completing a 14-day proxalutamide treatment significantly lowers death rates in hospitalized COVID-19 patients.

Effective pre- and post-operative care is crucial for better outcomes in sleeve gastrectomy patients.

Fatigue is the most common symptom in both ongoing symptomatic COVID-19 and post-COVID-19 syndrome.

Early treatment with azithromycin and other drugs reduced COVID-19 symptoms and complications.

Early treatment with azithromycin and other drugs reduced COVID-19 symptoms and complications.

Natural compounds, especially Withaferin-A, may help treat post-COVID-19 complications, but some may have side effects.

Sex hormones likely did not affect COVID-19 outcomes in South Korea.

The AndroCoV Clinical Scoring is a quick, accurate, and free tool for diagnosing COVID-19.

Cepharanthine is safe but not effective in significantly reducing COVID-19 recovery time.

Women are more likely to have long-term post-COVID symptoms than men.

Cosmeceuticals are important for managing skin issues during the COVID-19 pandemic.

Some COVID-19 patients lose hair, with the most common type linked to male hormones and possibly increasing the risk of severe illness.

Long COVID-19 patients with skin pain might have a nerve condition that responds to a medication called gabapentin.

Alopecia after COVID-19 negatively impacts quality of life, especially vitality.

Vitamin D may help prevent or reduce hair loss after COVID-19.

COVID-19 increased hair loss, especially in women, linked to Azithromycin use and symptoms like fatigue and skin irritation.

Post-COVID-19 hair loss can be treated effectively with therapies like light therapy, microneedling, and scalp massage.

Hair loss can happen after both mild and severe COVID-19, and areas with more COVID-19 cases may see more hair loss cases.

Some patients on immunosuppressants had a weaker immune response to the Sinovac-CoronaVac COVID-19 vaccine.

70.7% of patients had long-COVID symptoms like fatigue, cough, and brain fog three months after recovery.

COVID-19 patients often experience hair loss and scalp pain, which may be related to the severity of their infection and treatment drugs.

COVID-19 causes more taste, smell, hair, memory, and concentration issues than other respiratory infections.

People who had severe COVID-19 are more likely to experience hair loss.

More symptoms during initial COVID infection increase the risk of long-term effects.

FMH foods may help manage post-acute COVID-19 symptoms safely and easily.

Long COVID affects many survivors with ongoing symptoms, needing more research and care.

COVID-19 infection may trigger alopecia areata in some patients.

Vaccination and timely treatment reduce the risk of long COVID.